Structure

(S)-N-((3-(3-Fluoro-4-(piperazin-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide

CAS
154590-66-6
Catalog Number
ACM154590666
Category
Other Products
Molecular Weight
336.361343 [g/mol]
Molecular Formula
C16H21FN4O3

If you have any other questions or need other size, please get a quote.

  • Product Description
  • Case Study
  • Custom Reviews
  • Custom Q&A
  • Synthetic Use
  • Related Resources

Specification

Synonyms
154590-66-6, SureCN1894257, CHEMBL1651124, CTK4C8340, AKOS015924505, AKOS015995158, AG-L-59507, B-2133, (S)-N-((3-(3-fluoro-4-(piperazin-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide, Acetamide,N-[[(5S)-3-[3-fluoro-4-(1-piperazinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-
IUPAC Name
N-[[(5S)-3-(3-fluoro-4-piperazin-1-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide
InChI Key
DSRPYQXHWUDRBP-ZDUSSCGKSA-N
Exact Mass
336.16000
H-Bond Acceptor
6
H-Bond Donor
2

Upstream Synthesis Route 1

  • 174649-06-0
  • 154590-66-6

Reference: [1] Tetrahedron Letters, 2006, vol. 47, # 38, p. 6799 - 6802

Upstream Synthesis Route 2

  • 154590-65-5
  • 154590-66-6

Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 18, p. 5150 - 5155

Upstream Synthesis Route 3

  • 369-34-6
  • 154590-66-6

Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 19, p. 4261 - 4267
[2] Patent: WO2011/37731, 2011, A1,
[3] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 16, p. 4490 - 4498
[4] Patent: CN107033095, 2017, A,

Downstream Synthesis Route 1

  • 82419-35-0
  • 154590-66-6
  • 444335-14-2

Reference: [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 4213 - 4216

* For details of the synthesis route, please refer to the original source to ensure accuracy.

Please kindly note that our products are for research use only.

Alfa Chemistry

For product inquiries, please use our online system or send an email to .

Alfa Chemistry
Shopping basket
Loading...
Loading...
Download PDF documentDownload
* I hereby give my consent that I may receive marketing e-mails with information on existing and new services from this company. I know that I can opt-out from receiving such e-mails at any time or by using the link which will be provided in each marketing e-mail.